Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Research Article

Impact of the Vaccination Against COVID-19 on Frontline Health Workers

Author(s): Marcello M.C. Magri, David E. Uip, Flaviane K. Rodrigues, Elisangela R. Lima, Glaucia L. da Veiga*, Beatriz da C.A. Alves, Thaís Gascón, Ana C.M. Gaiatto, Thaciane A. Bibo, Nicolle de Godoy Moreira e Costa and Fernando Luiz Affonso Fonseca

Volume 18, Issue 4, 2023

Published on: 23 September, 2022

Page: [511 - 515] Pages: 5

DOI: 10.2174/1574886317666220620120444

Price: $65

Abstract

Introduction: Brazil has been facing the pandemic of COVID-19 since march 2020. More than 540,000 people have died from this disease in the country. Some estimates indicate that the population exposed to SARS-CoV-2 represents 1 to 20%. However, these data are questionable due to the number of asymptomatic and untested individuals. As a result, vaccination for COVID- 19 has become the main means of achieving herd immunity.

Objectives: To demonstrate, through local sampling, that broad and rapid vaccination may decrease the rate of COVID-19 detection in individuals potentially exposed to the SARS-CoV-2 virus.

Methods: A total of 1,128 individuals were studied, including students and health professionals from Centro Universitário FMABC, who received the two doses of the vaccine for COVID-19 (Oxford/Astrazeneca ® and CoronaVac®).

Results: In the studied period, there was a 41% reduction in the demand for RT-PCR tests after vaccination. And a 78.3% reduction in positive results after vaccination started.

Conclusion: The results of this study showed that even vaccinating a population with higher exposure to the risk of contamination significantly reduced test positivity and the demand to perform these tests. This emphasizes that vaccination is the best strategy to achieve herd immunity and reduce the spread of the disease.

Keywords: COVID-19, vaccination, RT-PCR, immunization, SARS-CoV-2, population.

Graphical Abstract
[1]
Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med 2020; 173(5): 362-7.
[http://dx.doi.org/10.7326/M20-3012] [PMID: 32491919]
[2]
Fontanet A, Cauchemez S. COVID-19 herd immunity: Where are we? Nat Rev Immunol 2020; 20(10): 583-4.
[http://dx.doi.org/10.1038/s41577-020-00451-5] [PMID: 32908300]
[3]
Greenwood B. The contribution of vaccination to global health: Past, present and future. Philos Trans R Soc Lond B Biol Sci 2014; 369(1645): 0433.
[http://dx.doi.org/10.1098/rstb.2013.0433] [PMID: 24821919]
[4]
Verani JFS, Laender F. Poliomyelitis eradication in four stages. Cad Saude Publica 2020; 36(S2): e00145720.
[5]
Balicer RD, Ohana R. Israel’s COVID-19 endgame. Science 2021; 372(6543): 663.
[http://dx.doi.org/10.1126/science.abj3858] [PMID: 33986155]
[6]
Butantan S. Project: remember Hilab's participation and learn about the developments of the study. 2022. Available from: https://hilab-com-br.translate.goog/blog/projeto-s/?_x_tr_sl=pt&_x_tr_tl=en&_ x_tr_hl=en&_x_tr_pto=sc
[7]
ANVISA National Health Surveilence Agency. Alert 3952 (Technovigilance) - Communiqué from the company Cmos Drake do Nordeste SA - Life 400 Futura Defibrillator - Usability Communicationfor the final consumer. 2022. Available from: https://antigoanvisa-gov-br.translate.goog/?_x_tr_sl=pt&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc&_x_tr_sch=http
[9]
United States. United states covid-19 cases, deaths, and laboratory testing (NAATs) by state, territory, and jurisdiction. Available from: https://covid.cdc.gov/covid-data-tracker/#vaccinations

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy